,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Death,5,16059921
0,22.0,Hepatocellular injury,2,16059950
1,22.0,Prescribed underdose,6,16059950
2,22.0,Atrial fibrillation,6,16059950
3,22.0,Renal failure,2,16059950
4,22.0,Pulmonary embolism,6,16059950
0,22.0,Breast cancer,5,16060009
1,22.0,Bronchial fistula,5,16060009
2,22.0,Pneumothorax,5,16060009
3,22.0,Tumour cavitation,6,16060009
0,21.1,Bone marrow failure,1,16060023
0,21.1,Parapsoriasis,6,16060032
1,21.1,Arthralgia,6,16060032
0,21.1,Rash generalised,6,16060049
0,21.1,Pancreatitis acute,5,16060148
1,21.1,Metastases to central nervous system,3,16060148
2,21.1,Hypothyroidism,1,16060148
3,21.1,Malignant neoplasm progression,3,16060148
0,22.0,Malignant neoplasm progression,6,16060164
1,22.0,Cardiac failure,6,16060164
2,22.0,Fulminant type 1 diabetes mellitus,3,16060164
3,22.0,Pleural effusion,2,16060164
4,22.0,Oedema peripheral,2,16060164
0,21.1,Disease recurrence,6,16060180
1,21.1,Acute myeloid leukaemia,6,16060180
2,21.1,Metastases to peritoneum,6,16060180
0,21.1,Cardiac tamponade,6,16060181
1,21.1,Malignant neoplasm progression,6,16060181
0,22.1,Tendonitis,3,16060226
1,22.1,Hypertension,1,16060226
2,22.1,Dysuria,1,16060226
3,22.1,Escherichia test positive,3,16060226
4,22.1,Fatigue,1,16060226
5,22.1,Tremor,1,16060226
6,22.1,Defaecation urgency,3,16060226
7,22.1,Neuropathy peripheral,1,16060226
8,22.1,Neuropathy peripheral,1,16060226
9,22.1,Anaphylactic reaction,1,16060226
10,22.1,Palmar erythema,3,16060226
11,22.1,Rash,1,16060226
12,22.1,Chest discomfort,1,16060226
13,22.1,Urosepsis,1,16060226
14,22.1,Bacterial test positive,1,16060226
15,22.1,Diarrhoea,1,16060226
16,22.1,Dyspnoea,1,16060226
17,22.1,Erythema,1,16060226
18,22.1,Cystitis noninfective,1,16060226
19,22.1,Hypersensitivity,1,16060226
20,22.1,Urinary tract infection,1,16060226
21,22.1,Malaise,1,16060226
22,22.1,Mucosal inflammation,1,16060226
0,21.1,Hip fracture,6,16060237
0,21.1,Diarrhoea,6,16060240
0,22.0,Eating disorder,6,16060297
1,22.0,Confusional state,6,16060297
2,22.0,Weight decreased,6,16060297
3,22.0,Dehydration,6,16060297
4,22.0,Night sweats,6,16060297
5,22.0,Gastrooesophageal reflux disease,6,16060297
6,22.0,Decreased appetite,6,16060297
7,22.0,Nausea,6,16060297
0,21.1,Chills,1,16060355
1,21.1,Muscle twitching,1,16060355
2,21.1,Tremor,1,16060355
0,21.1,White blood cell count decreased,6,16060361
1,21.1,Arthralgia,6,16060361
2,21.1,Fatigue,6,16060361
0,21.1,Hypoxia,1,16060368
1,21.1,Hyperhidrosis,1,16060368
2,21.1,Hypersensitivity,1,16060368
0,22.0,Gastrointestinal haemorrhage,1,16060375
1,22.0,Deep vein thrombosis,3,16060375
2,22.0,Acute kidney injury,1,16060375
0,21.1,Product dose omission,6,16060395
1,21.1,No adverse event,6,16060395
0,22.0,Neutropenia,6,16060561
1,22.0,Thrombocytopenia,6,16060561
2,22.0,Pyrexia,6,16060561
0,21.1,Anaemia,1,16060622
1,21.1,Neutropenia,1,16060622
2,21.1,Skin toxicity,1,16060622
3,21.1,Epistaxis,1,16060622
4,21.1,Febrile neutropenia,3,16060622
5,21.1,Polyneuropathy,1,16060622
6,21.1,Back pain,1,16060622
7,21.1,Nasopharyngitis,1,16060622
8,21.1,Nail toxicity,1,16060622
9,21.1,Diarrhoea,1,16060622
10,21.1,Pruritus,1,16060622
11,21.1,Alopecia,1,16060622
0,21.1,Paraesthesia,2,16060719
1,21.1,Dysarthria,2,16060719
2,21.1,Asthenia,2,16060719
3,21.1,Gait disturbance,2,16060719
0,21.1,Rash,1,16060737
1,21.1,Face oedema,1,16060737
0,22.0,Adverse event,6,16060740
0,21.1,Haemoglobin decreased,6,16060752
1,21.1,Feeling abnormal,6,16060752
2,21.1,Platelet count decreased,1,16060752
3,21.1,Red blood cell count abnormal,2,16060752
4,21.1,Memory impairment,6,16060752
5,21.1,Dyspnoea,2,16060752
6,21.1,White blood cell count decreased,1,16060752
7,21.1,Nausea,2,16060752
8,21.1,Dizziness,1,16060752
9,21.1,Alopecia,6,16060752
10,21.1,Aphasia,6,16060752
11,21.1,Feeling jittery,6,16060752
0,21.1,Paraesthesia,1,16060825
1,21.1,Macroglossia,1,16060825
0,21.1,Neutropenia,6,16060827
1,21.1,Nausea,6,16060827
2,21.1,Pyrexia,6,16060827
3,21.1,Visual impairment,6,16060827
4,21.1,Cognitive disorder,6,16060827
5,21.1,Fatigue,6,16060827
0,22.0,Small intestinal obstruction,1,16060924
0,21.1,Pruritus,6,16060925
1,21.1,Fatigue,6,16060925
0,21.1,Dry throat,6,16060927
1,21.1,Nasopharyngitis,6,16060927
0,21.1,Inflammation,3,16060931
1,21.1,Diverticulitis,3,16060931
0,21.1,No adverse event,6,16060933
1,21.1,Intentional product use issue,6,16060933
2,21.1,Off label use,6,16060933
0,21.1,No adverse event,6,16060935
1,21.1,Intentional product use issue,6,16060935
2,21.1,Off label use,6,16060935
0,21.1,Proteinuria,6,16060937
0,21.1,Constipation,3,16060939
1,21.1,Pain,6,16060939
2,21.1,Hepatomegaly,6,16060939
3,21.1,Weight decreased,6,16060939
4,21.1,Decreased appetite,6,16060939
5,21.1,Unevaluable event,6,16060939
0,21.1,Fistula,6,16060941
0,21.1,No adverse event,6,16060947
1,21.1,Intentional product use issue,6,16060947
2,21.1,Off label use,6,16060947
0,21.1,Haematochezia,6,16060950
0,21.1,Splenomegaly,6,16060952
1,21.1,Off label use,6,16060952
2,21.1,Intentional product use issue,6,16060952
0,21.1,Thrombocytopenia,6,16060953
0,21.1,Diarrhoea,6,16060954
1,21.1,Skin fissures,6,16060954
2,21.1,Skin discolouration,6,16060954
0,21.1,Liver disorder,6,16060960
1,21.1,Abdominal pain,3,16060960
2,21.1,Diarrhoea,3,16060960
0,21.1,Liver function test abnormal,6,16060963
0,21.1,Transient ischaemic attack,1,16060964
1,21.1,Increased viscosity of upper respiratory secretion,1,16060964
0,21.1,Drug ineffective,6,16060967
1,21.1,No adverse event,6,16060967
0,21.1,Blood bilirubin increased,6,16060968
0,21.1,Platelet count decreased,6,16060969
0,21.1,Drug ineffective,6,16060974
1,21.1,No adverse event,6,16060974
0,21.1,Thrombocytopenia,3,16060976
0,21.1,Hyperlipidaemia,1,16060986
1,21.1,Blood triglycerides increased,1,16060986
2,21.1,Blood cholesterol increased,1,16060986
0,21.1,Neuropathy peripheral,6,16060992
0,21.1,Rash,3,16060998
1,21.1,Mouth swelling,3,16060998
2,21.1,Peripheral swelling,3,16060998
0,21.1,Thrombocytopenia,6,16061001
1,21.1,Infusion related reaction,6,16061001
0,21.1,Hypertension,1,16061002
0,21.1,Gastrointestinal perforation,6,16061004
0,21.1,Recurrent cancer,6,16061007
1,21.1,Off label use,6,16061007
2,21.1,Intentional product use issue,6,16061007
0,21.1,Ejection fraction decreased,6,16061012
0,21.1,Acquired tracheo-oesophageal fistula,6,16061013
0,21.1,Peripheral swelling,3,16061014
1,21.1,Pain in extremity,3,16061014
2,21.1,Tendon pain,3,16061014
3,21.1,Drug ineffective,6,16061014
0,21.1,Acquired tracheo-oesophageal fistula,6,16061019
0,21.1,Blood pressure inadequately controlled,6,16061025
0,21.1,Myalgia,3,16061026
1,21.1,Arthralgia,3,16061026
0,21.1,Pneumonitis,3,16061029
1,21.1,Intentional product use issue,6,16061029
2,21.1,Off label use,6,16061029
0,21.1,Acute respiratory distress syndrome,5,16061045
1,21.1,Pneumonitis,6,16061045
0,21.1,Product preparation error,6,16061048
1,21.1,No adverse event,6,16061048
0,21.1,Hypertension,6,16061051
0,21.1,Large intestine perforation,2,16061053
0,21.1,Gastrointestinal perforation,1,16061055
0,21.1,Diarrhoea,2,16061067
1,21.1,Off label use,6,16061067
2,21.1,Intentional product use issue,6,16061067
3,21.1,Febrile neutropenia,1,16061067
0,21.1,Dysgeusia,6,16061100
0,21.1,Epistaxis,2,16061108
1,21.1,Ocular hyperaemia,2,16061108
2,21.1,Sunburn,2,16061108
3,21.1,Blister,2,16061108
4,21.1,Headache,3,16061108
5,21.1,Protein urine present,6,16061108
6,21.1,Urine abnormality,6,16061108
7,21.1,Fatigue,2,16061108
8,21.1,Hypertension,3,16061108
0,21.1,Arterial thrombosis,6,16061123
0,21.1,Cough,3,16061132
0,21.1,Off label use,6,16061135
1,21.1,No adverse event,6,16061135
2,21.1,Intentional product use issue,6,16061135
0,21.1,Pulmonary embolism,2,16061141
0,21.1,Hypertension,6,16061143
1,21.1,Cerebrovascular accident,6,16061143
0,21.1,Fistula,6,16061150
0,21.1,Mental disorder,6,16061152
0,21.1,Off label use,6,16061166
1,21.1,No adverse event,6,16061166
2,21.1,Intentional product use issue,6,16061166
0,21.1,Perforation,6,16061169
1,21.1,Intentional product use issue,6,16061169
2,21.1,Off label use,6,16061169
0,21.1,No adverse event,6,16061175
1,21.1,Product preparation error,6,16061175
0,21.1,Hordeolum,3,16061183
1,21.1,Epistaxis,1,16061183
2,21.1,Meibomian gland dysfunction,3,16061183
3,21.1,Nasal crusting,1,16061183
0,21.1,Gastrointestinal perforation,6,16061186
0,21.1,Musculoskeletal pain,6,16061194
0,21.1,Urticaria,1,16061203
0,21.1,Proteinuria,2,16061205
0,21.1,Hypertension,6,16061222
0,21.1,Product preparation issue,6,16061226
1,21.1,No adverse event,6,16061226
0,21.1,Liver function test increased,6,16061237
0,21.1,Sudden death,5,16061244
0,21.1,Chest pain,6,16061249
1,21.1,Dyspnoea,6,16061249
0,21.1,Fatigue,6,16061251
0,21.1,Dyspnoea,6,16061253
0,21.1,Gastrointestinal perforation,6,16061259
1,21.1,Sepsis,6,16061259
0,21.1,Myocardial infarction,6,16061260
0,21.1,Nausea,3,16061261
0,21.1,Metastases to skin,6,16061268
0,21.1,Dry skin,6,16061271
1,21.1,Neuralgia,6,16061271
0,21.1,Intestinal perforation,1,16061276
0,21.1,Abdominal pain upper,1,16061294
0,21.1,Cardiac failure congestive,1,16061295
0,21.1,Gastrointestinal perforation,3,16061302
0,21.1,Hypertension,6,16061312
0,21.1,Hypoaesthesia oral,6,16061315
0,21.1,Intestinal perforation,1,16061320
0,21.1,Thrombosis,1,16061332
1,21.1,Thrombosis,3,16061332
2,21.1,Phlebitis,6,16061332
0,21.1,Pregnancy,6,16061338
0,21.1,Blood pressure increased,3,16061344
1,21.1,Cognitive disorder,3,16061344
0,21.1,Intentional product use issue,6,16061348
1,21.1,Off label use,6,16061348
2,21.1,No adverse event,6,16061348
0,21.1,Insomnia,1,16061358
1,21.1,Off label use,6,16061358
2,21.1,Intentional product use issue,6,16061358
3,21.1,Headache,1,16061358
0,21.1,Chills,1,16061364
1,21.1,Hypertension,1,16061364
0,21.1,Alopecia,6,16061379
1,21.1,Asthenia,6,16061379
2,21.1,Rash,6,16061379
3,21.1,Fatigue,6,16061379
0,21.1,Radiation necrosis,6,16061381
0,21.1,No adverse event,6,16061386
1,21.1,Therapy partial responder,6,16061386
0,21.1,Speech disorder,3,16061389
1,21.1,Cerebrovascular accident,4,16061389
2,21.1,Cerebrovascular accident,3,16061389
0,21.1,Haemorrhage,6,16061390
0,21.1,No adverse event,6,16061393
1,21.1,Intentional product use issue,6,16061393
2,21.1,Off label use,6,16061393
0,21.1,Nausea,1,16061395
1,21.1,Rash erythematous,6,16061395
2,21.1,Pigmentation disorder,6,16061395
3,21.1,Skin discolouration,6,16061395
4,21.1,Tongue discolouration,6,16061395
5,21.1,Skin exfoliation,6,16061395
6,21.1,Vomiting,6,16061395
7,21.1,Tongue pigmentation,6,16061395
8,21.1,Decreased appetite,6,16061395
9,21.1,Tongue pruritus,6,16061395
10,21.1,Fatigue,6,16061395
11,21.1,Urine output decreased,1,16061395
12,21.1,Malaise,6,16061395
13,21.1,Pruritus,6,16061395
14,21.1,Gastrointestinal stoma output decreased,6,16061395
15,21.1,Drug ineffective,6,16061395
0,21.1,Platelet count decreased,3,16061397
1,21.1,Lymphadenopathy,3,16061397
0,21.1,No adverse event,6,16061399
1,21.1,Off label use,6,16061399
2,21.1,Intentional product use issue,6,16061399
0,21.1,No adverse event,6,16061414
1,21.1,Overdose,6,16061414
0,21.1,Gastrointestinal perforation,6,16061416
0,21.1,Hypertensive crisis,1,16061426
0,21.1,Platelet count decreased,6,16061428
0,21.1,Cardiac failure,6,16061431
0,21.1,Tinnitus,6,16061432
1,21.1,Intentional product use issue,6,16061432
2,21.1,Off label use,6,16061432
0,21.1,Back pain,3,16061433
0,21.1,Rectal haemorrhage,6,16061435
0,21.1,Memory impairment,6,16061438
1,21.1,Rhinorrhoea,6,16061438
2,21.1,Epistaxis,3,16061438
0,21.1,Micturition disorder,3,16061440
0,21.1,Cough,6,16061445
1,21.1,Nasal congestion,6,16061445
2,21.1,Wheezing,6,16061445
0,21.1,Posterior reversible encephalopathy syndrome,1,16061448
0,21.1,Dyspnoea,3,16061454
1,21.1,Pollakiuria,3,16061454
2,21.1,Rash,1,16061454
3,21.1,Diarrhoea,1,16061454
4,21.1,Palpitations,6,16061454
5,21.1,Aphonia,6,16061454
6,21.1,Fatigue,3,16061454
7,21.1,Haemoptysis,3,16061454
8,21.1,Hyperthyroidism,3,16061454
0,21.1,Proteinuria,3,16061456
0,21.1,Posterior reversible encephalopathy syndrome,1,16061459
0,21.1,Headache,2,16061488
0,21.1,Anastomotic leak,6,16061497
0,21.1,Off label use,6,16061502
1,21.1,No adverse event,6,16061502
2,21.1,Intentional product use issue,6,16061502
0,21.1,Nausea,6,16061504
1,21.1,Fatigue,6,16061504
2,21.1,Vomiting,6,16061504
3,21.1,Decreased appetite,6,16061504
4,21.1,Abdominal pain,6,16061504
0,21.1,Fatigue,6,16061508
1,21.1,Cellulitis,6,16061508
0,21.1,Protein urine present,1,16061514
0,21.1,Pulmonary hypertension,1,16061516
0,21.1,Urinary retention,1,16061517
0,21.1,Gastrointestinal perforation,6,16061522
0,22.1,Dry skin,3,16061527
1,22.1,Dyspnoea,1,16061527
2,22.1,Diarrhoea,1,16061527
3,22.1,Oedema peripheral,1,16061527
4,22.1,Pain in extremity,1,16061527
5,22.1,Pyrexia,1,16061527
6,22.1,Tachycardia,1,16061527
7,22.1,Protein total decreased,1,16061527
8,22.1,Anion gap decreased,3,16061527
9,22.1,Hypokalaemia,1,16061527
10,22.1,Haemoptysis,1,16061527
11,22.1,Blood urea increased,3,16061527
12,22.1,Neutrophil count decreased,1,16061527
13,22.1,Aspartate aminotransferase increased,1,16061527
14,22.1,White blood cell count decreased,1,16061527
15,22.1,Aspartate aminotransferase increased,1,16061527
16,22.1,Neutrophil count decreased,1,16061527
17,22.1,Hyperglycaemia,1,16061527
18,22.1,Hypoalbuminaemia,1,16061527
19,22.1,Anaemia,3,16061527
20,22.1,Aspartate aminotransferase increased,1,16061527
21,22.1,Aspartate aminotransferase increased,1,16061527
22,22.1,Gastric haemorrhage,4,16061527
23,22.1,Gastrointestinal fistula,1,16061527
24,22.1,Fatigue,3,16061527
25,22.1,Hypertension,1,16061527
26,22.1,Oedema,1,16061527
27,22.1,Gastrooesophageal reflux disease,1,16061527
28,22.1,Pain in extremity,1,16061527
29,22.1,Hypoalbuminaemia,3,16061527
30,22.1,Transferrin decreased,3,16061527
31,22.1,Blood folate decreased,3,16061527
32,22.1,Weight increased,1,16061527
33,22.1,Protein total increased,1,16061527
34,22.1,Lymphocyte count decreased,1,16061527
35,22.1,Hypertension,1,16061527
36,22.1,Rash maculo-papular,3,16061527
37,22.1,Dizziness,1,16061527
38,22.1,Anaemia,4,16061527
39,22.1,Oral pain,1,16061527
40,22.1,Hypothyroidism,3,16061527
41,22.1,Hypokalaemia,1,16061527
42,22.1,Hypocalcaemia,1,16061527
43,22.1,Osteoarthritis,1,16061527
44,22.1,Anaemia,1,16061527
45,22.1,Dizziness,1,16061527
46,22.1,Skin irritation,1,16061527
47,22.1,Hyperglycaemia,3,16061527
48,22.1,Neutrophil count decreased,1,16061527
49,22.1,Lymphocyte count decreased,1,16061527
50,22.1,Rash,1,16061527
51,22.1,Productive cough,3,16061527
52,22.1,Gastric haemorrhage,1,16061527
53,22.1,Headache,1,16061527
54,22.1,Dysphonia,3,16061527
55,22.1,Thrombophlebitis superficial,6,16061527
56,22.1,Blood iron decreased,3,16061527
57,22.1,Hyponatraemia,2,16061527
58,22.1,Amylase increased,1,16061527
59,22.1,Lymphocyte count decreased,3,16061527
60,22.1,White blood cell count increased,1,16061527
61,22.1,Lipase increased,1,16061527
62,22.1,Blood alkaline phosphatase increased,3,16061527
63,22.1,Blood creatinine decreased,1,16061527
64,22.1,Hypoalbuminaemia,1,16061527
65,22.1,Haemoptysis,2,16061527
66,22.1,Hypoalbuminaemia,3,16061527
67,22.1,Weight decreased,1,16061527
68,22.1,White blood cell count decreased,1,16061527
69,22.1,Neutrophil count decreased,1,16061527
70,22.1,Blood urea increased,1,16061527
71,22.1,Blood chloride increased,3,16061527
72,22.1,Melaena,1,16061527
73,22.1,Hypertension,1,16061527
74,22.1,Neutrophil count increased,1,16061527
75,22.1,Hyperglycaemia,1,16061527
76,22.1,Concomitant disease aggravated,3,16061527
77,22.1,Blood creatinine decreased,1,16061527
78,22.1,Lymphocyte count decreased,1,16061527
79,22.1,Hyperglycaemia,1,16061527
80,22.1,Pain,1,16061527
81,22.1,Decreased appetite,3,16061527
82,22.1,White blood cell count increased,1,16061527
83,22.1,Hypoalbuminaemia,1,16061527
84,22.1,Soft tissue disorder,1,16061527
85,22.1,Pruritus,1,16061527
86,22.1,Hypertension,3,16061527
87,22.1,Blood bilirubin increased,3,16061527
88,22.1,Chills,1,16061527
89,22.1,Weight increased,3,16061527
90,22.1,Aspartate aminotransferase increased,3,16061527
91,22.1,Pruritus,3,16061527
0,21.1,Malaise,6,16061537
0,22.1,Paraesthesia,6,16061550
1,22.1,Weight increased,6,16061550
2,22.1,Loss of personal independence in daily activities,6,16061550
3,22.1,Dizziness,6,16061550
0,22.0,Death,,16061552
0,21.1,General physical health deterioration,1,16061559
1,21.1,Gastroenteritis,1,16061559
2,21.1,Urinary tract disorder,1,16061559
0,21.1,Therapy non-responder,6,16061562
1,21.1,No adverse event,6,16061562
0,22.0,Paraesthesia,,16061572
0,22.0,Neutropenia,,16061589
0,22.1,Feeling abnormal,6,16061609
1,22.1,Dyspnoea,6,16061609
2,22.1,Vascular stenosis,6,16061609
3,22.1,Gait disturbance,6,16061609
4,22.1,Osteoarthritis,2,16061609
5,22.1,Increased appetite,6,16061609
6,22.1,Weight increased,6,16061609
7,22.1,Neoplasm progression,6,16061609
0,22.0,Neoplasm progression,5,16061614
1,22.0,Off label use,6,16061614
2,22.0,Product use in unapproved indication,6,16061614
0,22.0,Malaise,6,16061634
1,22.0,Laboratory test abnormal,6,16061634
0,22.1,Mouth ulceration,6,16061641
1,22.1,Neoplasm progression,6,16061641
2,22.1,White blood cell count decreased,6,16061641
0,21.1,Erythema,6,16061716
1,21.1,Blister,6,16061716
2,21.1,Pruritus,6,16061716
3,21.1,Dry skin,6,16061716
0,21.1,Haematuria,1,16061742
0,21.1,Lung disorder,1,16061750
0,22.1,Hair colour changes,3,16061784
1,22.1,Madarosis,3,16061784
2,22.1,Alopecia,3,16061784
3,22.1,Depression,6,16061784
4,22.1,Hair disorder,3,16061784
5,22.1,Hair texture abnormal,3,16061784
0,22.0,Hair texture abnormal,3,16061815
1,22.0,Hair disorder,3,16061815
2,22.0,Depression,6,16061815
3,22.0,Madarosis,3,16061815
4,22.0,Hair colour changes,3,16061815
5,22.0,Alopecia,3,16061815
0,22.0,Tumour marker increased,6,16061818
1,22.0,Blood count abnormal,3,16061818
0,21.1,Death,5,16061845
0,22.1,Walking aid user,6,16061854
1,22.1,Intentional dose omission,6,16061854
2,22.1,Mobility decreased,6,16061854
0,21.1,Death,5,16061883
0,21.1,Angiopathy,6,16061905
0,21.1,Pancreatitis acute,5,16061916
0,22.0,Nystagmus,2,16061936
1,22.0,Dizziness,2,16061936
2,22.0,Off label use,6,16061936
0,22.0,Disease progression,,16061949
0,22.1,Interstitial lung disease,2,16061951
0,21.1,Blister,6,16061965
1,21.1,Genital rash,6,16061965
0,22.0,Lethargy,3,16061966
1,22.0,Dementia,6,16061966
0,22.0,Stomatitis,1,16062000
1,22.0,Pyrexia,1,16062000
2,22.0,Fatigue,3,16062000
3,22.0,Malaise,1,16062000
4,22.0,Asthenia,1,16062000
5,22.0,Chills,1,16062000
6,22.0,Infection,1,16062000
7,22.0,Headache,1,16062000
8,22.0,Liver injury,1,16062000
0,21.1,Malignant neoplasm progression,3,16062012
0,21.1,Malignant neoplasm progression,6,16062013
1,21.1,Death,5,16062013
2,21.1,Pleural effusion,6,16062013
0,21.1,Pneumonitis,3,16062032
0,21.1,Diverticulum intestinal haemorrhagic,1,16062036
1,21.1,Prostatic specific antigen increased,3,16062036
2,21.1,Cardiovascular disorder,6,16062036
3,21.1,Transient ischaemic attack,1,16062036
4,21.1,Epistaxis,6,16062036
0,22.1,Anaemia,1,16062043
0,22.1,Fatigue,6,16062051
1,22.1,Head injury,1,16062051
2,22.1,Influenza like illness,1,16062051
3,22.1,Dizziness,1,16062051
4,22.1,Concussion,6,16062051
5,22.1,Muscle spasms,6,16062051
6,22.1,Fall,1,16062051
7,22.1,Herpes zoster,1,16062051
8,22.1,Hyperpyrexia,1,16062051
0,21.1,Deep vein thrombosis,6,16062055
1,21.1,Cholelithiasis,6,16062055
2,21.1,Peripheral swelling,6,16062055
3,21.1,Pleural effusion,6,16062055
4,21.1,Neutropenia,6,16062055
5,21.1,Skin irritation,6,16062055
6,21.1,Gastric volvulus,6,16062055
7,21.1,Hiatus hernia,6,16062055
8,21.1,Fungal infection,6,16062055
9,21.1,Blood pressure increased,6,16062055
10,21.1,Intestinal obstruction,6,16062055
11,21.1,Renal cyst,6,16062055
12,21.1,Ascites,6,16062055
13,21.1,Rheumatoid arthritis,6,16062055
14,21.1,Depression,6,16062055
15,21.1,Pancytopenia,6,16062055
16,21.1,Anxiety,6,16062055
17,21.1,Medical device site discharge,6,16062055
18,21.1,Lipids increased,6,16062055
19,21.1,Neoplasm progression,6,16062055
20,21.1,Rash,6,16062055
0,21.1,Blood count abnormal,6,16062056
1,21.1,Anaemia,6,16062056
0,21.1,Malignant neoplasm progression,6,16062153
0,21.1,Acute kidney injury,3,16062157
0,22.1,Dizziness,1,16062245
1,22.1,Eye discharge,1,16062245
0,21.1,Hair texture abnormal,3,16062246
1,21.1,Madarosis,3,16062246
2,21.1,Hair colour changes,3,16062246
3,21.1,Hair disorder,3,16062246
4,21.1,Alopecia,3,16062246
0,21.1,Pericarditis constrictive,6,16062272
1,21.1,Pericardial haemorrhage,6,16062272
0,22.0,Fall,6,16062277
1,22.0,Gait disturbance,6,16062277
2,22.0,Lower limb fracture,6,16062277
3,22.0,Balance disorder,6,16062277
0,21.1,Respiratory tract infection,2,16062304
1,21.1,Hot flush,3,16062304
2,21.1,Pneumonia,6,16062304
0,21.1,Interstitial lung disease,1,16062310
0,21.1,Product use in unapproved indication,6,16062321
1,21.1,Adverse event,6,16062321
2,21.1,Malignant neoplasm progression,5,16062321
0,21.1,Chondrosarcoma,6,16062331
0,21.1,Nausea,6,16062335
1,21.1,Vomiting,6,16062335
2,21.1,Condition aggravated,6,16062335
3,21.1,Drug interaction,6,16062335
4,21.1,Gastrooesophageal reflux disease,6,16062335
0,21.1,Alopecia,2,16062355
1,21.1,Psychological trauma,6,16062355
0,22.1,Alopecia,2,16062356
1,22.1,Impaired quality of life,6,16062356
2,22.1,Emotional distress,6,16062356
3,22.1,Pain,6,16062356
4,22.1,Anxiety,6,16062356
5,22.1,Psychological trauma,6,16062356
0,21.1,Alopecia,3,16062358
1,21.1,Pain,6,16062358
2,21.1,Impaired quality of life,6,16062358
3,21.1,Anxiety,6,16062358
4,21.1,Emotional distress,6,16062358
0,21.1,Osteonecrosis of jaw,1,16062369
1,21.1,Disease complication,5,16062369
2,21.1,Tooth extraction,6,16062369
0,22.0,Nausea,2,16062387
1,22.0,Rash pruritic,1,16062387
2,22.0,Leukopenia,2,16062387
3,22.0,Neutropenia,1,16062387
4,22.0,Product dose omission,6,16062387
5,22.0,Neuropathy peripheral,6,16062387
6,22.0,Dysgeusia,2,16062387
7,22.0,Dizziness postural,1,16062387
8,22.0,Off label use,6,16062387
9,22.0,Product use issue,6,16062387
10,22.0,Glossodynia,6,16062387
11,22.0,Blister,2,16062387
12,22.0,Fatigue,3,16062387
13,22.0,Diffuse alopecia,6,16062387
0,21.1,Acute myeloid leukaemia,6,16062398
0,22.0,Alopecia,2,16062412
0,22.0,Alopecia,2,16062424
0,21.1,Neoplasm progression,6,16062446
0,21.1,Hair disorder,3,16062447
1,21.1,Hair colour changes,3,16062447
2,21.1,Hair texture abnormal,3,16062447
3,21.1,Alopecia,3,16062447
0,22.1,Pulmonary oedema,6,16062451
1,22.1,Ascites,6,16062451
2,22.1,Dyspnoea,1,16062451
3,22.1,Hiccups,6,16062451
4,22.1,Dyspnoea,6,16062451
5,22.1,Death,5,16062451
6,22.1,Inflammation,6,16062451
7,22.1,Pruritus,6,16062451
8,22.1,Musculoskeletal pain,6,16062451
9,22.1,Abdominal discomfort,6,16062451
10,22.1,Oedema peripheral,6,16062451
11,22.1,Abdominal distension,6,16062451
12,22.1,Lacrimation increased,6,16062451
13,22.1,Hypoxia,6,16062451
14,22.1,Chest pain,6,16062451
15,22.1,Eructation,6,16062451
16,22.1,Abdominal pain upper,6,16062451
0,21.1,Peripheral swelling,6,16062452
0,22.0,Hair disorder,3,16062456
1,22.0,Hair colour changes,3,16062456
2,22.0,Madarosis,3,16062456
3,22.0,Alopecia,3,16062456
4,22.0,Hair texture abnormal,3,16062456
0,22.1,Malignant neoplasm progression,5,16062457
1,22.1,Hyperkalaemia,1,16062457
2,22.1,Shock haemorrhagic,1,16062457
3,22.1,Blood pressure systolic increased,6,16062457
4,22.1,General physical health deterioration,6,16062457
5,22.1,Cell death,1,16062457
6,22.1,Urinary incontinence,3,16062457
7,22.1,Lactic acidosis,2,16062457
8,22.1,Heart rate decreased,6,16062457
9,22.1,Hypothyroidism,2,16062457
10,22.1,Oedema peripheral,6,16062457
11,22.1,Renal cancer metastatic,5,16062457
12,22.1,Anaemia,1,16062457
13,22.1,Psychomotor retardation,1,16062457
14,22.1,Metastases to central nervous system,5,16062457
15,22.1,Shock,1,16062457
16,22.1,Blood pressure systolic decreased,6,16062457
17,22.1,Diarrhoea,1,16062457
18,22.1,Acute kidney injury,2,16062457
19,22.1,Diarrhoea,2,16062457
20,22.1,Malnutrition,1,16062457
21,22.1,Hyperleukocytosis,1,16062457
22,22.1,Constipation,3,16062457
23,22.1,Intestinal transit time abnormal,3,16062457
24,22.1,Coma,1,16062457
25,22.1,Metabolic acidosis,6,16062457
26,22.1,Decreased appetite,6,16062457
27,22.1,Haematoma,6,16062457
28,22.1,Vitamin D deficiency,1,16062457
29,22.1,Peripheral artery haematoma,6,16062457
30,22.1,Staphylococcal sepsis,2,16062457
31,22.1,Pruritus,1,16062457
32,22.1,Dehydration,1,16062457
33,22.1,Vomiting,1,16062457
34,22.1,Staphylococcal infection,1,16062457
35,22.1,Pneumonia,2,16062457
36,22.1,Accidental overdose,6,16062457
37,22.1,Asthenia,3,16062457
0,21.1,Product use in unapproved indication,6,16062484
1,21.1,Death,5,16062484
0,21.1,Psychological trauma,6,16062516
1,21.1,Alopecia,3,16062516
0,21.1,Alopecia,2,16062525
0,22.0,Tuberculosis,6,16062550
1,22.0,Off label use,6,16062550
2,22.0,Drug interaction,6,16062550
0,21.1,Constipation,1,16062561
1,21.1,Leukopenia,2,16062561
2,21.1,Abdominal pain,3,16062561
3,21.1,Leukopenia,1,16062561
4,21.1,Abdominal pain,1,16062561
5,21.1,Anaemia,1,16062561
6,21.1,Stress,1,16062561
7,21.1,Alopecia,3,16062561
8,21.1,Abdominal pain,1,16062561
9,21.1,Gastrointestinal disorder,3,16062561
10,21.1,Nausea,1,16062561
11,21.1,Constipation,1,16062561
12,21.1,Abdominal pain,1,16062561
0,22.1,Urinary tract infection,1,16062562
1,22.1,Urinary tract infection,1,16062562
2,22.1,Muscle tightness,3,16062562
3,22.1,Nervous system disorder,3,16062562
4,22.1,Micturition disorder,3,16062562
5,22.1,Paraesthesia,3,16062562
0,21.1,Pleural effusion,2,16062569
1,21.1,Pruritus,6,16062569
2,21.1,Cough,6,16062569
3,21.1,Palpitations,6,16062569
4,21.1,Aortic valve stenosis,6,16062569
5,21.1,Aortic valve incompetence,6,16062569
0,21.1,Malignant neoplasm progression,6,16062570
0,22.0,Device leakage,6,16062615
1,22.0,Injection site pain,6,16062615
2,22.0,Breast cancer recurrent,6,16062615
3,22.0,Incorrect dose administered,6,16062615
4,22.0,Needle issue,6,16062615
0,21.1,Enteritis,1,16062623
0,22.0,White blood cell count decreased,1,16062632
1,22.0,Erythema,1,16062632
2,22.0,Disease progression,5,16062632
3,22.0,Hyperuricaemia,1,16062632
4,22.0,Febrile neutropenia,1,16062632
0,21.1,Enteritis,1,16062634
0,21.1,Vasoplegia syndrome,1,16062647
1,21.1,Diarrhoea,1,16062647
2,21.1,Blood pressure decreased,1,16062647
3,21.1,Shock,6,16062647
4,21.1,Hyperthermia,1,16062647
5,21.1,Hypersensitivity,6,16062647
6,21.1,Erythema,1,16062647
0,21.1,Hypersensitivity,6,16062648
1,21.1,Rash erythematous,1,16062648
2,21.1,Vasoplegia syndrome,1,16062648
3,21.1,Diarrhoea,1,16062648
4,21.1,Blood pressure decreased,1,16062648
5,21.1,Shock,6,16062648
6,21.1,Hyperthermia,1,16062648
0,21.1,Shock,6,16062650
1,21.1,Diarrhoea,1,16062650
2,21.1,Hypersensitivity,6,16062650
3,21.1,Rash erythematous,1,16062650
4,21.1,Vasoplegia syndrome,1,16062650
5,21.1,Blood pressure decreased,1,16062650
6,21.1,Hyperthermia,1,16062650
0,21.1,Inappropriate schedule of product administration,6,16062652
0,22.0,Neutrophil count decreased,1,16062659
1,22.0,Death,5,16062659
2,22.0,Acute myocardial infarction,6,16062659
3,22.0,Ventricular septal defect acquired,6,16062659
0,22.0,Blood glucose increased,6,16062678
1,22.0,Nausea,1,16062678
2,22.0,Asthenia,6,16062678
3,22.0,Protein urine present,6,16062678
4,22.0,Blood pressure increased,1,16062678
5,22.0,Product dose omission,6,16062678
6,22.0,Malaise,6,16062678
7,22.0,Feeling abnormal,6,16062678
8,22.0,Decreased appetite,2,16062678
0,21.1,Hypersensitivity,6,16062684
1,21.1,Rash erythematous,1,16062684
2,21.1,Hyperthermia,1,16062684
3,21.1,Blood pressure decreased,1,16062684
4,21.1,Shock,6,16062684
5,21.1,Diarrhoea,1,16062684
6,21.1,Vasoplegia syndrome,1,16062684
0,22.0,Lung disorder,2,16062736
1,22.0,Hypertension,2,16062736
0,21.1,Bone marrow failure,6,16062750
1,21.1,Aplasia pure red cell,6,16062750
2,21.1,Anaemia,6,16062750
3,21.1,Thrombocytopenia,1,16062750
4,21.1,Neutropenia,1,16062750
0,21.1,Death,5,16062764
0,21.1,Hepatitis,2,16062766
1,21.1,Depressed mood,2,16062766
0,21.1,Hepatotoxicity,5,16062776
0,21.1,Death,5,16062793
0,22.0,Pneumonia,1,16062854
1,22.0,Bronchitis,1,16062854
0,21.1,Neoplasm progression,6,16062909
0,21.1,Nasopharyngeal cancer metastatic,5,16063031
0,21.1,Nausea,3,16063090
1,21.1,Vomiting,3,16063090
2,21.1,Electrolyte imbalance,3,16063090
0,22.1,Intestinal obstruction,1,16063098
1,22.1,Tooth infection,2,16063098
2,22.1,Proteinuria,3,16063098
3,22.1,Abdominal pain,1,16063098
4,22.1,Stomatitis,3,16063098
5,22.1,Nausea,1,16063098
6,22.1,Diarrhoea,1,16063098
7,22.1,Skin laceration,1,16063098
8,22.1,Nasal crusting,3,16063098
9,22.1,Fatigue,3,16063098
10,22.1,Dyspnoea,3,16063098
11,22.1,Foreign body in eye,1,16063098
12,22.1,Salivary hypersecretion,1,16063098
13,22.1,Eye irritation,1,16063098
14,22.1,Epistaxis,1,16063098
15,22.1,Vomiting,1,16063098
0,22.0,Seizure,6,16063157
1,22.0,Chest pain,1,16063157
2,22.0,Dyspnoea,6,16063157
3,22.0,Hypertension,2,16063157
4,22.0,Gait disturbance,6,16063157
5,22.0,Anaemia,1,16063157
6,22.0,Eating disorder symptom,6,16063157
7,22.0,Ageusia,6,16063157
8,22.0,Pericardial effusion,6,16063157
9,22.0,Palpitations,6,16063157
10,22.0,Alopecia,2,16063157
0,21.1,Tracheitis,3,16063160
1,21.1,Leukopenia,6,16063160
2,21.1,Diarrhoea,3,16063160
3,21.1,Cough,3,16063160
0,22.0,Hair disorder,3,16063229
1,22.0,Alopecia,3,16063229
2,22.0,Hair texture abnormal,3,16063229
3,22.0,Hair colour changes,3,16063229
4,22.0,Madarosis,3,16063229
0,22.0,Infusion related reaction,1,16063243
1,22.0,Pneumonia,1,16063243
0,22.0,Neutropenia,1,16063245
0,21.1,Gastrointestinal toxicity,1,16063246
1,21.1,Diarrhoea,1,16063246
2,21.1,Neutropenia,,16063246
3,21.1,Pyrexia,1,16063246
4,21.1,Vomiting,1,16063246
5,21.1,Dehydration,1,16063246
0,21.1,Pneumothorax,2,16063249
0,22.1,Constipation,3,16063256
1,22.1,Acute kidney injury,1,16063256
2,22.1,Decreased appetite,6,16063256
3,22.1,Diarrhoea,1,16063256
4,22.1,Nausea,1,16063256
5,22.1,Vomiting,1,16063256
6,22.1,Asthenia,6,16063256
7,22.1,Dehydration,1,16063256
8,22.1,Malaise,1,16063256
0,21.1,Toxicity to various agents,1,16063268
0,21.1,Drug interaction,6,16063273
1,21.1,Neoplasm progression,5,16063273
0,22.0,Uterine polyp,6,16063303
1,22.0,Dysphonia,2,16063303
0,21.1,Influenza,6,16063312
1,21.1,Myalgia,6,16063312
2,21.1,Emotional disorder,6,16063312
3,21.1,Abdominal discomfort,6,16063312
4,21.1,Fatigue,6,16063312
5,21.1,Breast mass,2,16063312
0,22.1,Radiation pneumonitis,2,16063332
0,21.1,Septic shock,1,16063350
1,21.1,Dizziness,3,16063350
2,21.1,Epistaxis,1,16063350
3,21.1,Paraesthesia,3,16063350
4,21.1,Multi-organ disorder,1,16063350
5,21.1,Electrolyte imbalance,1,16063350
6,21.1,Pneumonia,1,16063350
7,21.1,Sepsis,1,16063350
8,21.1,Cardiac failure,1,16063350
9,21.1,General physical health deterioration,1,16063350
10,21.1,Acute respiratory failure,1,16063350
11,21.1,Aortic valve incompetence,3,16063350
12,21.1,Mitral valve incompetence,2,16063350
13,21.1,Erythema,1,16063350
14,21.1,Tricuspid valve incompetence,1,16063350
15,21.1,Tachyarrhythmia,1,16063350
16,21.1,Atrial fibrillation,6,16063350
17,21.1,Acute respiratory distress syndrome,1,16063350
18,21.1,Lacrimation increased,3,16063350
19,21.1,Dyspnoea,1,16063350
0,21.1,Weight increased,6,16063388
1,21.1,Diabetes mellitus,6,16063388
0,21.1,Thrombocytopenia,5,16063393
0,21.1,Bone marrow failure,1,16063409
0,21.1,Bone marrow failure,1,16063433
0,22.1,Cough,1,16063480
1,22.1,Urinary incontinence,1,16063480
2,22.1,Depression,1,16063480
3,22.1,Insomnia,1,16063480
0,21.1,Gastroenteritis,2,16063583
0,21.1,Renal cancer,,16063592
0,21.1,Madarosis,3,16063621
1,21.1,Hair texture abnormal,3,16063621
2,21.1,Alopecia,3,16063621
3,21.1,Hair disorder,3,16063621
4,21.1,Hair colour changes,3,16063621
0,21.1,Vomiting,6,16063622
0,21.1,Hair colour changes,3,16063627
1,21.1,Hair texture abnormal,3,16063627
2,21.1,Alopecia,3,16063627
3,21.1,Madarosis,3,16063627
4,21.1,Hair disorder,3,16063627
0,21.1,Alopecia,3,16063630
1,21.1,Madarosis,3,16063630
2,21.1,Hair colour changes,3,16063630
3,21.1,Hair texture abnormal,3,16063630
4,21.1,Hair disorder,3,16063630
0,21.1,Gamma-glutamyltransferase increased,1,16063632
1,21.1,Nausea,1,16063632
2,21.1,Jaundice,1,16063632
3,21.1,Malignant neoplasm progression,,16063632
4,21.1,Breast cancer metastatic,5,16063632
5,21.1,Hepatic function abnormal,,16063632
0,22.0,Neoplasm progression,6,16063639
0,21.1,Neoplasm malignant,6,16063645
1,21.1,Malignant neoplasm progression,6,16063645
0,22.1,Interstitial lung disease,1,16063646
1,22.1,Malignant neoplasm progression,5,16063646
2,22.1,Pleural effusion,6,16063646
0,21.1,Dyspnoea,6,16063671
1,21.1,Deafness,6,16063671
2,21.1,Vertigo,3,16063671
0,21.1,Cough,1,16063734
0,21.1,Peripheral swelling,6,16063760
0,22.0,Middle insomnia,,16063779
1,22.0,Dysphonia,,16063779
2,22.0,Retching,,16063779
3,22.0,Liver function test increased,1,16063779
4,22.0,Fatigue,,16063779
5,22.0,Vomiting,,16063779
6,22.0,Epistaxis,,16063779
7,22.0,Blister infected,1,16063779
8,22.0,Product dose omission,,16063779
9,22.0,Constipation,3,16063779
10,22.0,Vomiting,1,16063779
11,22.0,Dehydration,,16063779
12,22.0,Off label use,,16063779
13,22.0,Vomiting,,16063779
14,22.0,Asthenia,,16063779
15,22.0,Hypertension,,16063779
16,22.0,Decreased appetite,,16063779
17,22.0,Poor quality sleep,,16063779
18,22.0,Dehydration,,16063779
0,21.1,Death,5,16063854
0,22.0,Hepatic enzyme increased,2,16063858
0,22.0,Stomatitis,2,16063859
0,21.1,Malignant neoplasm progression,5,16063874
0,21.1,Urinary incontinence,3,16063924
1,21.1,Blood pressure increased,3,16063924
2,21.1,Cerebrovascular accident,3,16063924
3,21.1,Decreased appetite,3,16063924
4,21.1,Retching,1,16063924
5,21.1,Hypotension,1,16063924
6,21.1,Gait disturbance,3,16063924
7,21.1,Fatigue,3,16063924
8,21.1,Wrist fracture,3,16063924
9,21.1,Blood potassium increased,3,16063924
10,21.1,Hypersomnia,3,16063924
11,21.1,Dysarthria,3,16063924
12,21.1,Nausea,3,16063924
13,21.1,Heart rate decreased,3,16063924
14,21.1,Anal incontinence,3,16063924
15,21.1,Dysphonia,3,16063924
16,21.1,Blood bilirubin increased,3,16063924
0,21.1,Anaemia,3,16063962
1,21.1,Pneumonia,5,16063962
2,21.1,Respiratory failure,5,16063962
3,21.1,Thrombocytopenia,3,16063962
0,21.1,Death,5,16063972
0,22.1,Cough,6,16063973
1,22.1,White blood cell count decreased,6,16063973
2,22.1,Platelet count decreased,6,16063973
3,22.1,Red cell distribution width increased,6,16063973
4,22.1,Neuropathy peripheral,6,16063973
5,22.1,Creatinine renal clearance decreased,6,16063973
6,22.1,Red blood cell count decreased,6,16063973
7,22.1,Neutrophil count decreased,6,16063973
8,22.1,Lymphoedema,3,16063973
9,22.1,Mean cell volume increased,6,16063973
10,22.1,Haematocrit decreased,6,16063973
0,21.1,Hepatic enzyme increased,2,16064099
0,21.1,Pulmonary embolism,2,16064101
0,21.1,Cardiac arrest,5,16064108
0,21.1,Blood pressure increased,6,16064124
0,21.1,Death,5,16064150
0,21.1,Death,5,16064151
0,21.1,Death,5,16064152
0,21.1,Death,5,16064153
0,21.1,Hypertension,6,16064182
1,21.1,Diabetes mellitus,6,16064182
2,21.1,Breast cancer,6,16064182
0,21.1,Hypotension,3,16064212
1,21.1,Vomiting,2,16064212
0,21.1,Urinary tract infection,6,16064220
1,21.1,Off label use,6,16064220
0,21.1,Nausea,2,16064247
1,21.1,Weight decreased,2,16064247
2,21.1,Diarrhoea,2,16064247
3,21.1,Dehydration,2,16064247
0,21.1,Fluid retention,1,16064307
0,21.1,Off label use,6,16064332
0,22.0,Diarrhoea,1,16064338
1,22.0,Acute kidney injury,3,16064338
0,21.1,Anaphylactoid shock,1,16064390
0,21.1,Pneumonia,6,16064514
0,21.1,Malignant neoplasm progression,6,16064515
1,21.1,Breast cancer metastatic,6,16064515
0,22.0,Pyrexia,1,16064543
1,22.0,Sepsis,1,16064543
2,22.0,Systemic infection,1,16064543
3,22.0,Inflammation,1,16064543
4,22.0,Bacteraemia,1,16064543
5,22.0,Bacterial translocation,1,16064543
6,22.0,Klebsiella infection,1,16064543
0,22.0,Hypothyroidism,2,16064544
1,22.0,Fulminant type 1 diabetes mellitus,2,16064544
0,21.1,Prostatic specific antigen increased,3,16064595
1,21.1,Synovial cyst,3,16064595
2,21.1,Skeletal injury,3,16064595
3,21.1,Asthenia,6,16064595
4,21.1,Metastases to lymph nodes,3,16064595
5,21.1,Metastases to bone,3,16064595
6,21.1,Performance status decreased,6,16064595
0,22.1,Pulmonary oedema,1,16064596
1,22.1,General physical health deterioration,6,16064596
2,22.1,Death,5,16064596
3,22.1,Hypertensive crisis,1,16064596
4,22.1,Orthopnoea,1,16064596
5,22.1,Pulmonary congestion,6,16064596
0,21.1,Anaemia,6,16064599
1,21.1,Red blood cell count decreased,6,16064599
2,21.1,Heart rate decreased,6,16064599
3,21.1,Renal failure,6,16064599
4,21.1,Mean cell haemoglobin increased,6,16064599
5,21.1,Basophil count increased,6,16064599
6,21.1,Haemoglobin decreased,6,16064599
7,21.1,Mean cell volume increased,6,16064599
8,21.1,Hot flush,6,16064599
9,21.1,Haematocrit decreased,6,16064599
10,21.1,Red cell distribution width increased,6,16064599
11,21.1,Blood creatinine increased,6,16064599
12,21.1,Leukopenia,6,16064599
0,22.0,Bone marrow failure,1,16064627
0,21.1,Cellulitis,6,16064734
1,21.1,Fatigue,6,16064734
0,21.1,Immune-mediated necrotising myopathy,5,16064893
1,21.1,Necrotising myositis,5,16064893
2,21.1,Hyperthyroidism,6,16064893
3,21.1,Blood pressure decreased,6,16064893
4,21.1,Sepsis,6,16064893
5,21.1,Malignant neoplasm progression,6,16064893
6,21.1,Respiratory failure,5,16064893
7,21.1,Physical deconditioning,6,16064893
8,21.1,Dysphagia,6,16064893
9,21.1,Haemoptysis,6,16064893
10,21.1,Dysarthria,6,16064893
11,21.1,Tachycardia,6,16064893
0,22.0,Ageusia,6,16064974
1,22.0,Photosensitivity reaction,6,16064974
2,22.0,Asthenia,6,16064974
3,22.0,Neuropathy peripheral,6,16064974
4,22.0,Decreased appetite,6,16064974
5,22.0,Skin irritation,6,16064974
6,22.0,Peripheral swelling,6,16064974
7,22.0,Rash,6,16064974
8,22.0,Urticaria,6,16064974
9,22.0,Epistaxis,3,16064974
10,22.0,Faeces soft,6,16064974
11,22.0,Dry skin,6,16064974
12,22.0,Diarrhoea,6,16064974
13,22.0,Paraesthesia,6,16064974
14,22.0,Erythema,6,16064974
15,22.0,Dysgraphia,6,16064974
16,22.0,Weight increased,6,16064974
17,22.0,Nail disorder,6,16064974
18,22.0,Bowel movement irregularity,6,16064974
19,22.0,Joint swelling,6,16064974
20,22.0,Fatigue,6,16064974
21,22.0,Pruritus,6,16064974
22,22.0,Concomitant disease aggravated,6,16064974
0,22.1,Lymphopenia,6,16064981
1,22.1,Staphylococcal bacteraemia,6,16064981
2,22.1,Oedema,6,16064981
3,22.1,Hypertension,6,16064981
4,22.1,Pyrexia,1,16064981
5,22.1,Oesophageal candidiasis,6,16064981
6,22.1,Prerenal failure,2,16064981
7,22.1,Spondylolisthesis,6,16064981
8,22.1,Oral candidiasis,6,16064981
9,22.1,Pancytopenia,6,16064981
10,22.1,Temperature regulation disorder,6,16064981
11,22.1,Erythema multiforme,6,16064981
12,22.1,Blood lactate dehydrogenase increased,6,16064981
13,22.1,Product use in unapproved indication,6,16064981
14,22.1,Leukopenia,6,16064981
15,22.1,Neutropenia,6,16064981
16,22.1,Superinfection,6,16064981
17,22.1,Vulvovaginal candidiasis,6,16064981
18,22.1,Hypokalaemia,6,16064981
19,22.1,Primary hypothyroidism,6,16064981
20,22.1,Malnutrition,6,16064981
21,22.1,Osteoarthritis,6,16064981
22,22.1,Dysphagia,6,16064981
23,22.1,Anaemia,2,16064981
24,22.1,Hypoalbuminaemia,6,16064981
25,22.1,Back pain,3,16064981
26,22.1,Stevens-Johnson syndrome,2,16064981
27,22.1,Vitamin D deficiency,6,16064981
28,22.1,Fluid overload,6,16064981
29,22.1,Scar,6,16064981
30,22.1,Psychomotor disadaptation syndrome,6,16064981
0,22.0,Hair colour changes,6,16065053
1,22.0,Alopecia,2,16065053
2,22.0,Therapeutic response decreased,6,16065053
0,21.1,Cytopenia,1,16065102
1,21.1,Hepatic function abnormal,3,16065102
0,22.0,Disease progression,1,16065120
1,22.0,Dermatitis acneiform,2,16065120
2,22.0,Hypersensitivity,1,16065120
3,22.0,Colon cancer,1,16065120
0,21.1,Toxicity to various agents,6,16065125
0,21.1,Macroglossia,1,16065129
1,21.1,Paraesthesia,1,16065129
0,21.1,Feeling abnormal,3,16065133
1,21.1,Sluggishness,3,16065133
2,21.1,Decreased appetite,3,16065133
3,21.1,Fatigue,3,16065133
0,22.0,Oedema peripheral,1,16065144
1,22.0,Urinary retention,1,16065144
2,22.0,Colony stimulating factor therapy,6,16065144
3,22.0,Liver disorder,1,16065144
0,21.1,Death,5,16065197
0,21.1,Dermatitis acneiform,6,16065214
1,21.1,Product use in unapproved indication,6,16065214
0,21.1,Alopecia,6,16065240
1,21.1,Toxicity to various agents,6,16065240
2,21.1,Fatigue,6,16065240
0,21.1,Interstitial lung disease,5,16065248
0,21.1,Respiratory disorder,1,16065342
1,21.1,Blood pressure decreased,1,16065342
2,21.1,Dyspnoea,1,16065342
3,21.1,Anaphylactic shock,1,16065342
0,21.1,Thrombocytopenia,3,16065375
1,21.1,Chronic kidney disease,3,16065375
2,21.1,Drug hypersensitivity,6,16065375
0,22.0,Adverse drug reaction,6,16065474
0,22.0,Product use in unapproved indication,6,16065527
1,22.0,Inappropriate schedule of product administration,6,16065527
2,22.0,Ureteral stent insertion,6,16065527
3,22.0,Catheter placement,6,16065527
0,21.1,Chemotherapy,6,16065578
1,21.1,Blood urine present,6,16065578
0,21.1,Lip dry,2,16065641
1,21.1,Lip exfoliation,1,16065641
2,21.1,Lip pain,1,16065641
3,21.1,Chapped lips,2,16065641
4,21.1,Cheilitis,1,16065641
5,21.1,Lip erythema,2,16065641
0,22.0,Product preparation issue,6,16065657
1,22.0,Underdose,6,16065657
2,22.0,Metastases to bone,6,16065657
3,22.0,Gait disturbance,6,16065657
4,22.0,Lipids increased,6,16065657
5,22.0,Hot flush,6,16065657
6,22.0,Prostatic specific antigen increased,6,16065657
7,22.0,Muscle atrophy,6,16065657
8,22.0,Muscle twitching,6,16065657
9,22.0,Dry mouth,6,16065657
10,22.0,Blood glucose increased,6,16065657
11,22.0,Eczema,1,16065657
12,22.0,Product administration error,6,16065657
0,22.0,Hypersensitivity vasculitis,2,16065827
1,22.0,Bacterial infection,2,16065827
2,22.0,Dermatitis acneiform,1,16065827
3,22.0,Purpura,2,16065827
4,22.0,Paronychia,1,16065827
0,21.1,Radiation pneumonitis,1,16065845
0,22.0,Blister,2,16065846
0,22.0,Hospice care,,16065944
0,22.0,Disease progression,,16065950
0,22.0,White blood cell count decreased,,16065959
1,22.0,Cough,,16065959
0,21.1,Rhinalgia,3,16065978
0,22.0,Dizziness,3,16066022
1,22.0,Off label use,6,16066022
2,22.0,Paraesthesia,3,16066022
3,22.0,Dysphagia,3,16066022
4,22.0,Chest pain,3,16066022
5,22.0,Dyspnoea,1,16066022
6,22.0,Malaise,3,16066022
7,22.0,Palpitations,3,16066022
8,22.0,Disturbance in attention,3,16066022
9,22.0,Ataxia,3,16066022
10,22.0,Cardiac dysfunction,1,16066022
11,22.0,Fatigue,3,16066022
12,22.0,Tremor,3,16066022
13,22.0,Asthenia,3,16066022
14,22.0,Condition aggravated,6,16066022
0,21.1,Ill-defined disorder,6,16066023
1,21.1,Neutropenia,1,16066023
0,21.1,Acute febrile neutrophilic dermatosis,2,16066037
0,21.1,Diarrhoea,2,16066061
1,21.1,Dysuria,2,16066061
2,21.1,Paraesthesia,2,16066061
3,21.1,Pyrexia,2,16066061
0,21.1,Drug ineffective,6,16066121
1,21.1,Malignant neoplasm progression,6,16066121
0,22.0,Death,5,16066145
1,22.0,Intentional product use issue,6,16066145
0,21.1,Malignant neoplasm progression,6,16066147
1,21.1,Breast cancer metastatic,6,16066147
0,22.0,Therapy cessation,,16066185
1,22.0,Cerebrovascular accident,,16066185
0,21.1,Hot flush,2,16066191
1,21.1,Cold sweat,6,16066191
0,21.1,Seizure,6,16066202
1,21.1,Mental status changes,3,16066202
2,21.1,Metastases to central nervous system,6,16066202
0,21.1,Pneumonia,4,16066243
0,22.0,Blood test abnormal,,16066269
0,22.0,Death,,16066277
0,22.0,Fall,,16066281
0,21.1,Dehydration,6,16066286
0,22.0,Disease progression,,16066311
0,22.0,Pyrexia,6,16066328
1,22.0,Nausea,3,16066328
2,22.0,Dehydration,6,16066328
3,22.0,Muscle spasms,6,16066328
4,22.0,Cancer pain,3,16066328
5,22.0,Decreased appetite,3,16066328
6,22.0,Weight decreased,2,16066328
7,22.0,Hot flush,3,16066328
8,22.0,Dizziness,2,16066328
9,22.0,Constipation,3,16066328
10,22.0,Sinusitis,6,16066328
11,22.0,Hyperchlorhydria,6,16066328
12,22.0,Abdominal pain,3,16066328
13,22.0,Respiratory tract infection,6,16066328
14,22.0,Muscle injury,6,16066328
15,22.0,Vaginal discharge,6,16066328
16,22.0,White blood cell count decreased,3,16066328
17,22.0,Condition aggravated,3,16066328
18,22.0,Diarrhoea,2,16066328
19,22.0,Rhinitis allergic,6,16066328
20,22.0,Insomnia,6,16066328
0,22.0,No adverse event,6,16066345
0,21.1,Chest pain,6,16066347
1,21.1,Gait inability,6,16066347
0,22.0,Renal failure,1,16066366
1,22.0,Loss of personal independence in daily activities,3,16066366
2,22.0,Bradyphrenia,2,16066366
3,22.0,Blood creatinine increased,3,16066366
4,22.0,Platelet count decreased,1,16066366
5,22.0,Abdominal pain upper,6,16066366
6,22.0,Wrong product administered,6,16066366
7,22.0,Laboratory test abnormal,6,16066366
8,22.0,Memory impairment,1,16066366
9,22.0,Cognitive disorder,3,16066366
10,22.0,International normalised ratio decreased,3,16066366
11,22.0,Sleep disorder due to a general medical condition,6,16066366
12,22.0,Hypertension,6,16066366
13,22.0,Malaise,3,16066366
14,22.0,Balance disorder,3,16066366
15,22.0,Urine abnormality,6,16066366
16,22.0,Rhinorrhoea,1,16066366
17,22.0,Renal disorder,6,16066366
18,22.0,Emotional distress,6,16066366
19,22.0,Urinary tract infection,6,16066366
20,22.0,Epistaxis,1,16066366
21,22.0,Blood sodium decreased,3,16066366
22,22.0,Blood urea increased,6,16066366
23,22.0,Feeling abnormal,3,16066366
24,22.0,Intestinal obstruction,6,16066366
25,22.0,Disease progression,6,16066366
26,22.0,Diarrhoea,6,16066366
27,22.0,Electrolyte imbalance,1,16066366
28,22.0,Muscle spasms,6,16066366
29,22.0,Dehydration,1,16066366
30,22.0,Confusional state,3,16066366
31,22.0,Blood urine present,6,16066366
32,22.0,Tremor,6,16066366
33,22.0,Eastern Cooperative Oncology Group performance status worsened,6,16066366
34,22.0,Carbohydrate antigen 125 increased,3,16066366
35,22.0,Red blood cell count decreased,6,16066366
36,22.0,White blood cell count decreased,6,16066366
37,22.0,Insomnia,3,16066366
38,22.0,Product dose omission,6,16066366
39,22.0,Nausea,2,16066366
40,22.0,Drug intolerance,6,16066366
0,22.0,Disease progression,,16066403
0,21.1,Colorectal cancer,,16066409
1,21.1,Drug ineffective,,16066409
0,22.0,Colon cancer,,16066435
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16066435
0,21.1,Colon cancer,,16066437
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16066438
1,22.0,Colon cancer,,16066438
0,21.1,Colon cancer,,16066442
0,21.1,Colon cancer,,16066445
1,21.1,Cachexia,,16066445
2,21.1,Palmar-plantar erythrodysaesthesia syndrome,,16066445
0,22.0,Colon cancer,,16066446
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16066446
0,22.0,Colon cancer,,16066450
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16066450
0,21.1,Wrong technique in product usage process,6,16066451
1,21.1,Acute respiratory failure,5,16066451
2,21.1,Pneumonia aspiration,5,16066451
3,21.1,Dysphagia,5,16066451
4,21.1,Muscular weakness,5,16066451
5,21.1,Hip fracture,3,16066451
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16066454
1,22.0,Colon cancer,,16066454
0,21.1,Left ventricular dysfunction,1,16066469
1,21.1,Left ventricular dysfunction,2,16066469
0,22.0,Disease progression,5,16066479
1,22.0,Multiple organ dysfunction syndrome,6,16066479
0,22.0,Headache,1,16066486
1,22.0,Fatigue,3,16066486
2,22.0,Chills,6,16066486
3,22.0,Upper respiratory tract infection bacterial,1,16066486
4,22.0,Bone marrow failure,6,16066486
5,22.0,Arthralgia,6,16066486
6,22.0,Pain in extremity,6,16066486
7,22.0,Laryngitis,6,16066486
8,22.0,Stomatitis,1,16066486
9,22.0,Leukopenia,2,16066486
10,22.0,Pain,6,16066486
11,22.0,Back pain,6,16066486
12,22.0,Nausea,6,16066486
0,21.1,Bone marrow failure,6,16066487
1,21.1,Dry skin,6,16066487
2,21.1,Somnolence,6,16066487
3,21.1,Xerosis,2,16066487
4,21.1,Blister,6,16066487
0,21.1,Cytopenia,1,16066490
1,21.1,Death,5,16066490
0,21.1,Death,5,16066516
0,21.1,Jaundice,1,16066540
0,21.1,Death,5,16066570
0,22.0,Hypokalaemia,6,16066586
1,22.0,Night sweats,6,16066586
0,22.0,Gamma-glutamyltransferase increased,2,16066607
0,21.1,Prostate cancer metastatic,3,16066609
1,21.1,Dysphagia,3,16066609
2,21.1,Adverse event,6,16066609
3,21.1,Haemoptysis,6,16066609
0,21.1,Myositis,6,16066611
1,21.1,Muscle abscess,6,16066611
2,21.1,Prostatic specific antigen increased,6,16066611
0,21.1,Haemoglobin decreased,6,16066614
1,21.1,Upper gastrointestinal haemorrhage,2,16066614
2,21.1,Oesophageal ulcer,6,16066614
3,21.1,Gastrointestinal erosion,6,16066614
4,21.1,Duodenal polyp,6,16066614
0,21.1,Drug ineffective,6,16066644
1,21.1,Dysphagia,6,16066644
2,21.1,Disease progression,6,16066644
3,21.1,Thrombosis,6,16066644
0,22.0,Skin fissures,,16066657
1,22.0,Diarrhoea,,16066657
2,22.0,Neuropathy peripheral,,16066657
0,22.0,Diarrhoea,,16066669
0,22.0,Death,,16066674
0,21.1,Ovarian cancer recurrent,6,16066687
0,22.0,Death,,16066709
0,22.0,Urticaria,,16066819
0,21.1,Pain,3,16066861
1,21.1,Faecaloma,2,16066861
0,22.0,Asthenia,3,16066868
1,22.0,Fatigue,,16066868
2,22.0,Prostatic specific antigen increased,,16066868
3,22.0,Nausea,,16066868
4,22.0,Pain,,16066868
5,22.0,Headache,,16066868
6,22.0,Hot flush,,16066868
7,22.0,Decreased appetite,,16066868
0,21.1,Blood test abnormal,,16066870
0,21.1,Shock,5,16066884
1,21.1,Hypersensitivity,5,16066884
2,21.1,Cardiac arrest,5,16066884
0,21.1,Arthralgia,6,16066900
0,21.1,Coma,5,16067017
1,21.1,Hemiplegia,,16067017
2,21.1,Central nervous system lesion,,16067017
3,21.1,Motor dysfunction,,16067017
4,21.1,Asthenia,,16067017
5,21.1,Off label use,,16067017
0,22.0,Death,5,16067034
1,22.0,Therapeutic product effect incomplete,6,16067034
0,22.0,Hyponatraemia,,16067049
1,22.0,Asthenia,,16067049
0,21.1,Breast cancer,3,16067072
0,22.0,Sensory loss,3,16067121
1,22.0,Eschar,3,16067121
2,22.0,Death,5,16067121
3,22.0,Motor dysfunction,3,16067121
4,22.0,Gait disturbance,3,16067121
5,22.0,Vomiting,1,16067121
6,22.0,Mobility decreased,3,16067121
7,22.0,Haemoglobin decreased,3,16067121
8,22.0,Head injury,3,16067121
9,22.0,Fall,3,16067121
0,21.1,Hot flush,3,16067149
1,21.1,Malignant neoplasm progression,6,16067149
0,21.1,Stomatitis,1,16067203
0,22.0,Pyrexia,1,16067253
1,22.0,Hyperglycaemia,1,16067253
2,22.0,Anaemia,1,16067253
3,22.0,C-reactive protein increased,1,16067253
4,22.0,Product use in unapproved indication,6,16067253
5,22.0,Pneumonia bacterial,1,16067253
0,21.1,Blood count abnormal,6,16067261
1,21.1,Thrombocytopenia,6,16067261
2,21.1,Joint swelling,6,16067261
0,21.1,Haematochezia,6,16067262
1,21.1,Febrile neutropenia,2,16067262
2,21.1,Eating disorder,2,16067262
3,21.1,Diarrhoea,1,16067262
0,22.0,Snoring,6,16067273
1,22.0,Pain in extremity,6,16067273
2,22.0,Dyspnoea,6,16067273
3,22.0,Neutropenia,1,16067273
4,22.0,Haemoptysis,6,16067273
5,22.0,Movement disorder,6,16067273
0,21.1,Pancreatitis,2,16067298
0,22.1,Urethral stent insertion,6,16067306
1,22.1,Urethral stent insertion,1,16067306
2,22.1,Renal cancer,6,16067306
3,22.1,Prostatic specific antigen abnormal,6,16067306
4,22.1,Gastric neoplasm,3,16067306
5,22.1,Injection site erythema,1,16067306
6,22.1,Hot flush,3,16067306
7,22.1,Rash,6,16067306
8,22.1,Bile duct stone,6,16067306
0,22.0,Proteinuria,1,16067362
1,22.0,Fatigue,1,16067362
0,22.0,Hospice care,,16067372
0,22.0,Neutropenia,,16067379
0,21.1,Radiotherapy,6,16067424
0,21.1,Cerebrovascular accident,6,16067431
0,21.1,Blood count abnormal,3,16067458
1,21.1,Circumstance or information capable of leading to medication error,3,16067458
2,21.1,Red blood cell count decreased,6,16067458
3,21.1,White blood cell count decreased,6,16067458
0,21.1,Flatulence,3,16067501
1,21.1,Confusional state,3,16067501
2,21.1,Abnormal faeces,3,16067501
3,21.1,Hypoacusis,3,16067501
4,21.1,Visual impairment,3,16067501
5,21.1,Lethargy,3,16067501
6,21.1,Breath odour,3,16067501
7,21.1,Feeling abnormal,3,16067501
8,21.1,Asthenia,3,16067501
9,21.1,Drug interaction,6,16067501
0,22.0,Death,5,16067529
0,21.1,Condition aggravated,6,16067531
1,21.1,Neoplasm progression,6,16067531
2,21.1,Pericardial effusion,6,16067531
0,22.0,Hair texture abnormal,3,16067547
1,22.0,Hair disorder,3,16067547
2,22.0,Major depression,6,16067547
3,22.0,Alopecia,3,16067547
4,22.0,Hair colour changes,3,16067547
0,21.1,Gilbert^s syndrome,6,16067548
0,22.1,Hepatitis B reactivation,6,16067554
1,22.1,Acute hepatic failure,6,16067554
0,22.0,Anal fistula,1,16067592
1,22.0,Anal fissure,1,16067592
0,22.0,Thinking abnormal,1,16067622
1,22.0,Neoplasm progression,6,16067622
2,22.0,White blood cell count decreased,1,16067622
3,22.0,Malaise,1,16067622
4,22.0,Memory impairment,1,16067622
0,21.1,Diarrhoea,6,16067642
1,21.1,Fatigue,6,16067642
2,21.1,Dizziness,6,16067642
0,21.1,Thyroid cancer,3,16067656
0,22.0,Chest discomfort,,16067666
1,22.0,Flushing,,16067666
0,22.0,Death,,16067672
0,21.1,Dyspnoea,6,16067681
1,21.1,Urinary tract infection,6,16067681
2,21.1,Weight decreased,6,16067681
3,21.1,Urinary retention,6,16067681
4,21.1,Pulmonary embolism,6,16067681
0,21.1,Cholangitis,2,16067707
1,21.1,Hepatitis,2,16067707
2,21.1,Drug-induced liver injury,2,16067707
3,21.1,Hypersensitivity,2,16067707
0,21.1,Prostatic specific antigen increased,3,16067735
1,21.1,Skeletal injury,3,16067735
2,21.1,Asthenia,6,16067735
3,21.1,Performance status decreased,6,16067735
4,21.1,Synovial cyst,3,16067735
0,22.1,Malignant neoplasm progression,5,16067738
0,22.0,Colon cancer metastatic,5,16067758
0,22.0,Therapy cessation,,16067844
1,22.0,Hospitalisation,,16067844
0,21.1,Hypertension,2,16067894
1,21.1,Mental status changes,2,16067894
0,21.1,Deep vein thrombosis,6,16067913
1,21.1,Peripheral artery thrombosis,6,16067913
2,21.1,Oedema peripheral,6,16067913
0,21.1,Delirium,6,16067930
1,21.1,Somnolence,6,16067930
0,22.0,Pleural effusion,6,16067934
1,22.0,Dyspnoea,6,16067934
2,22.0,Death,5,16067934
3,22.0,Pericardial effusion,6,16067934
4,22.0,Cardiac failure,6,16067934
5,22.0,Dermatitis acneiform,6,16067934
6,22.0,Liver disorder,1,16067934
7,22.0,Product dose omission,6,16067934
0,22.0,Haemoptysis,2,16067935
1,22.0,Bronchial fistula,1,16067935
0,22.0,Pyrexia,1,16067963
1,22.0,General physical health deterioration,1,16067963
2,22.0,Asthenia,1,16067963
3,22.0,Vascular access site infection,2,16067963
0,22.0,Neuropathy peripheral,3,16067978
1,22.0,Muscle spasms,3,16067978
2,22.0,Back pain,3,16067978
0,21.1,Death,5,16067985
0,21.1,Death,5,16067986
0,22.0,Haematotoxicity,1,16068025
0,21.1,Myelodysplastic syndrome,3,16068029
1,21.1,Refractory anaemia with an excess of blasts,3,16068029
0,21.1,Stevens-Johnson syndrome,6,16068128
1,21.1,Pneumonia,6,16068128
0,21.1,Erythema,1,16068191
1,21.1,Nausea,1,16068191
2,21.1,Paraesthesia,1,16068191
0,21.1,Multiple organ dysfunction syndrome,5,16068192
0,22.0,Malignant neoplasm progression,6,16068254
1,22.0,Oedema,1,16068254
2,22.0,Hypertension,1,16068254
0,22.0,Malignant neoplasm progression,6,16068258
1,22.0,Hypertension,3,16068258
2,22.0,Oedema,1,16068258
0,22.0,Pleural effusion,6,16068268
0,22.0,Liver disorder,6,16068272
1,22.0,Feeling hot,6,16068272
2,22.0,Dizziness,2,16068272
3,22.0,Cardiac disorder,6,16068272
4,22.0,Pallor,3,16068272
5,22.0,Pain in extremity,3,16068272
6,22.0,Peripheral swelling,3,16068272
7,22.0,Vomiting,6,16068272
8,22.0,Vomiting,1,16068272
0,21.1,Chills,1,16068315
1,21.1,Thrombocytopenia,3,16068315
2,21.1,Palpitations,1,16068315
3,21.1,Flushing,1,16068315
4,21.1,Pruritus,1,16068315
0,21.1,Malignant neoplasm progression,3,16068318
1,21.1,Off label use,1,16068318
2,21.1,Dyspnoea,3,16068318
3,21.1,Weight decreased,6,16068318
4,21.1,Salivary gland cancer,5,16068318
0,22.0,Skin lesion,,16068361
1,22.0,Prostate cancer metastatic,,16068361
2,22.0,Dermatitis allergic,,16068361
3,22.0,General physical health deterioration,,16068361
4,22.0,Pruritus,,16068361
0,21.1,Blood pressure increased,1,16068398
1,21.1,Dyspnoea,1,16068398
2,21.1,Respiratory rate increased,1,16068398
3,21.1,Abdominal pain,1,16068398
4,21.1,Rhonchi,1,16068398
5,21.1,Chest pain,1,16068398
6,21.1,Erythema,1,16068398
0,21.1,Carbohydrate antigen 125 increased,6,16068411
1,21.1,Metastases to peritoneum,6,16068411
0,21.1,Colon cancer,,16068423
0,22.0,Anaphylactic shock,1,16068470
0,21.1,Alopecia,2,16068490
1,21.1,Infusion related reaction,1,16068490
2,21.1,Neutropenia,2,16068490
3,21.1,Onychomycosis,2,16068490
4,21.1,Feeling hot,1,16068490
0,22.0,Diarrhoea,6,16068510
1,22.0,General physical health deterioration,1,16068510
2,22.0,Nausea,6,16068510
3,22.0,Back pain,6,16068510
4,22.0,Asthenia,6,16068510
5,22.0,Oliguria,6,16068510
6,22.0,Flank pain,6,16068510
7,22.0,Hypophagia,6,16068510
0,21.1,Urticaria,6,16068517
1,21.1,Eyelid oedema,6,16068517
0,21.1,Neutropenia,2,16068520
1,21.1,Embolism,2,16068520
0,21.1,Asthenia,3,16068530
1,21.1,Blood pressure increased,3,16068530
2,21.1,Amnesia,3,16068530
0,21.1,Enteritis,1,16068554
1,21.1,Colitis,1,16068554
2,21.1,Febrile neutropenia,1,16068554
0,22.1,Dysphagia,1,16068566
1,22.1,Fatigue,1,16068566
2,22.1,Vomiting,1,16068566
3,22.1,Bacteraemia,1,16068566
0,22.1,Skin fissures,3,16068645
1,22.1,Stomatitis,6,16068645
2,22.1,Pain in extremity,3,16068645
3,22.1,Nasal dryness,3,16068645
4,22.1,Dry eye,3,16068645
5,22.1,Stomatitis,3,16068645
6,22.1,Skin haemorrhage,6,16068645
7,22.1,Blood pressure increased,3,16068645
8,22.1,Diarrhoea,2,16068645
9,22.1,Blister,6,16068645
10,22.1,Dry skin,3,16068645
11,22.1,Paronychia,6,16068645
12,22.1,Muscle spasms,3,16068645
0,21.1,Fracture,3,16068674
1,21.1,Fall,6,16068674
0,22.0,Rhabdomyolysis,1,16068677
0,22.0,Urinary retention,1,16068679
0,21.1,Acute myeloid leukaemia,3,16068712
0,22.1,Alopecia,3,16068719
1,22.1,Hair disorder,3,16068719
2,22.1,Hair texture abnormal,3,16068719
3,22.1,Hair colour changes,3,16068719
0,22.0,Interstitial lung disease,1,16068723
1,22.0,Infectious pleural effusion,6,16068723
2,22.0,Purpura,2,16068723
3,22.0,Pleural effusion,1,16068723
4,22.0,Pulmonary artery dilatation,6,16068723
5,22.0,Atrial fibrillation,6,16068723
6,22.0,Pulmonary hypertension,6,16068723
0,21.1,Off label use,6,16068777
1,21.1,Myeloid leukaemia,6,16068777
0,21.1,Drug interaction,1,16068866
1,21.1,Shock haemorrhagic,1,16068866
0,22.0,Alopecia,2,16068922
0,21.1,Alopecia,2,16068938
0,22.1,Alopecia,3,16068947
0,22.0,Liver function test increased,1,16069028
1,22.0,Fatigue,3,16069028
2,22.0,Malignant neoplasm progression,6,16069028
3,22.0,Thrombosis,6,16069028
4,22.0,Malaise,6,16069028
5,22.0,Nasopharyngitis,6,16069028
6,22.0,Product dose omission,6,16069028
7,22.0,Cough,3,16069028
8,22.0,Liver function test abnormal,3,16069028
9,22.0,Therapy partial responder,6,16069028
0,21.1,Renal impairment,6,16069057
0,21.1,Encephalitis,6,16069135
0,22.0,Malignant neoplasm progression,5,16069136
0,21.1,Radiation pneumonitis,1,16069137
0,22.0,General physical health deterioration,5,16069139
1,22.0,Paralysis recurrent laryngeal nerve,3,16069139
2,22.0,Malignant neoplasm progression,5,16069139
0,21.1,Neutropenia,6,16069184
1,21.1,Cognitive disorder,6,16069184
2,21.1,Pyrexia,6,16069184
3,21.1,Nausea,6,16069184
4,21.1,Visual impairment,6,16069184
5,21.1,Fatigue,6,16069184
0,21.1,Breast cancer recurrent,6,16069186
1,21.1,Drug ineffective,6,16069186
0,22.0,Calciphylaxis,1,16069230
1,22.0,Pain,1,16069230
2,22.0,Ulcer,1,16069230
3,22.0,Off label use,6,16069230
0,22.0,Haemoptysis,6,16069278
1,22.0,Lung disorder,1,16069278
0,22.0,Decubitus ulcer,2,16069297
1,22.0,Metastases to liver,2,16069297
0,21.1,Death,5,16069301
0,22.0,Pulmonary hypertension,6,16069305
0,22.0,Alopecia,2,16069441
0,21.1,Insomnia,1,16069479
1,21.1,Irritability,1,16069479
2,21.1,Leukocytosis,6,16069479
3,21.1,Mood swings,1,16069479
0,21.1,Dyspnoea,6,16069480
1,21.1,Lymphoedema,3,16069480
2,21.1,Pain in extremity,6,16069480
3,21.1,Pneumonia,6,16069480
0,22.0,Vasculitis,2,16069530
1,22.0,Physical deconditioning,6,16069530
0,21.1,Renal haemorrhage,6,16069580
0,22.0,Interstitial lung disease,3,16069655
1,22.0,Sjogren^s syndrome,6,16069655
0,21.1,Bone marrow failure,2,16069659
0,21.1,Vomiting,2,16069686
1,21.1,Decreased appetite,2,16069686
2,21.1,Nausea,2,16069686
3,21.1,Bone marrow failure,2,16069686
0,22.0,Nausea,6,16069699
1,22.0,Decreased appetite,6,16069699
2,22.0,Ileus,1,16069699
3,22.0,Gastritis erosive,1,16069699
4,22.0,Malignant neoplasm progression,6,16069699
5,22.0,Interstitial lung disease,1,16069699
6,22.0,Gastroenteritis,6,16069699
0,21.1,Skin mass,3,16069732
1,21.1,Product use in unapproved indication,6,16069732
2,21.1,Arthralgia,3,16069732
3,21.1,Chest pain,3,16069732
0,21.1,Colitis,1,16069735
0,21.1,Cardiac failure,6,16069756
1,21.1,Weight decreased,6,16069756
0,22.0,Myasthenia gravis,5,16069828
1,22.0,Myositis,5,16069828
0,22.0,Mass,6,16069854
1,22.0,Therapeutic agent-diagnostic test interaction,6,16069854
0,21.1,Hepatocellular injury,2,16069859
0,21.1,Neoplasm progression,4,16069919
1,21.1,Neuropathy peripheral,4,16069919
0,22.0,Bladder disorder,6,16069954
1,22.0,Cystitis,3,16069954
2,22.0,Product dose omission,6,16069954
3,22.0,Cystitis,6,16069954
0,21.1,Tachycardia,6,16069958
1,21.1,Dyspnoea,6,16069958
0,21.1,Product use in unapproved indication,6,16069969
1,21.1,Nausea,6,16069969
2,21.1,Malaise,6,16069969
0,21.1,Pericardial effusion,6,16069997
1,21.1,Axillary pain,6,16069997
